COHANCE LIFESCIENCES
Back to Income Statement
|
COHANCE LIFESCIENCES Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹797 Cr | ₹406 Cr | ₹57,416 Cr | ₹582 Cr | ₹443 Cr |
What is the latest Operating Profit of COHANCE LIFESCIENCES ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹797 Cr |
| Mar2025 | ₹406 Cr |
| Mar2024 | ₹57,416 Cr |
| Mar2023 | ₹582 Cr |
| Mar2022 | ₹443 Cr |
How is Operating Profit of COHANCE LIFESCIENCES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹797 Cr | 96.41 | |
| Mar2025 | ₹406 Cr | -99.29 | |
| Mar2024 | ₹57,416 Cr | 9,770.06 | |
| Mar2023 | ₹582 Cr | 31.31 | |
| Mar2022 | ₹443 Cr | - | |
Compare Operating Profit of peers of COHANCE LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| COHANCE LIFESCIENCES | ₹18,041.5 Cr | 8.8% | 7.9% | -34.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 1.4% | 6.7% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹303,962.0 Cr | 11.1% | 23.5% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.2% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 0.1% | 6% | -5.8% | Stock Analytics | |
COHANCE LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| COHANCE LIFESCIENCES | 8.8% |
7.9% |
-34.3% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses